Multiple Sclerosis (MS) Drugs & Exposure before, during, and after Pregnancy

    Basic Details
    Status
    Complete
    Last Updated
    Thursday, December 6, 2018
    Health Outcome(s)
    exposure before, during, and after pregnancy
    Purpose
    Drug Use
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    No
    Regulatory Determination / Use

    Contextualized enrollment and recruitment in MS pregnancy registries. Described patterns of drug use before, during, and after pregnancy.